Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation

Author： Nishikori T.   Irie K.   Suganuma T.   Ozaki M.   Yoshioka T.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.451, Iss.3, 2002-09, pp. : 327-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

By Chopra Puneet   Kanoje Vijay   Semwal Arvind   Ray Abhijit  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite

p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 867-874

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Relationships of p38 Mitogen-Activated Protein Kinase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-01 ,pp. : 857-868

Bentham Science Publishers

Access to resources Recommend Favorite

P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production

By Lahti A.   Kankaanranta H.   Moilanen E.  

European Journal of Pharmacology, Vol. 454, Iss. 2, 2002-11 ,pp. : 115-123

Elsevier

Access to resources Recommend Favorite

Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and gastric mucosal inflammatory reaction to Helicobacter pylori lipopolysaccharide

By Slomiany B. L.   Slomiany A.  

Inflammopharmacology, Vol. 8, Iss. 4, 2000-12 ,pp. : 371-382

VSP

Access to resources Recommend Favorite